MARCHF5 and diabetic cardiomyopathy: In 2023, another group showed that irisin—a myokine—rescued cardiac dysfunction in diabetic cardiomyopathy by activating mitochondrial ubiquitin ligase MITOL (also known as MARCH5) and suppressing NLRP3 inflammasome activity through the inhibition of the cGAS/STING pathway [36].